Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Round 2 'Innovation' Bills Adopted; Funding Fight Ahead

This article was originally published in Scrip

Executive Summary

A second set of bills intended to overhaul the US biomedical enterprise, aimed at accelerating the discovery, development and approval processes for medical products, mostly had smooth sailing through the Senate Health, Education, Labor and Pensions (HELP) Committee on March 9, with only a somewhat brief debate over how the measures will be funded holding up the votes for a short time.


Related Content

Gene Therapy Guidances Will Focus On Specific Diseases, Gottlieb Says





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts